Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

GSK appoints Bas Vorsteveld as vice president for Great Britain and Ireland

GSK Consumer Healthcare has appointed Bas Vorsteveld as vice president and general manager for Great Britain and Ireland.

Mr Vorsteveld has more than 15 years of experience in the healthcare industry and has been with GSK for more than six years, most recently holding the role of VP and head of commercial excellence for the Europe, the Middle East and Africa and the Latin America regions at GSK Consumer Healthcare.

He takes over the role of general manager from Jonathan Workman, who held the position from 2018 and has now moved into the role of business unit general manager for Northern Europe.

Commenting on his new role, Mr Vorsteveld said: “I am incredibly honoured to have been a part of GSK Consumer Healthcare’s journey to date and it is our collective ambition to deliver better everyday health with humanity for our customers, with a laser focus on ‘self-care’.

“We remain on track to split GSK into two separate companies in 2022, one of which will be a world-leading standalone consumer healthcare company, and I look forward to leading the Great Britain and Ireland Consumer Healthcare business through what I’m sure will be many exciting years ahead.”

GSK has also appointed Monica Michalopoulou as marketing director and Onyeka Anugwom as commercial excellence director for its Great Britain and Ireland division.

Topics


         
Pharmacist
Yeovil, Winchester & Dorchester
£50-55,000 per annum

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD135873

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel